Skip to content
Recall Observatory FDA recall evidence

Drug product

Wegovy (semaglutide) injection, 2.4 mg/0.75 mL, 4 Single-Dose Prefilled Pens per Carton, For Subcutaneous Use Only, Rx Only, Single-Dose Only, Novo Nordisk Inc., Plainsboro, NJ 08536, Manufactured by: Novo Nordisk A/S, DK-2880, Bagsvaerd, Denmark, NDC 0169-4524-14.

D-0393-2025

April 09, 2025

Class II

Product summary

Firm
Cardinal Health Inc.
Event
Event 96637
Status
Ongoing
Classification
Class II
Quantity
48 Cartons
Official record key
drug-enforcement:D-0393-2025

Official wording

Reason: Temperature abuse: Wegovy product was potentially exposed to temperatures outside of the products labeled storage conditions due to a shipping error involving a Cardinal Health distribution center. More specifically, product was removed from refrigerated storage for an extended period of time and inappropriately released.

Code information: Lot PZFDE06, Exp 08/31/2025

Distribution pattern: NC, SC, VA

Derived failure modes

  • Unknown

    reason.no_named_rule · v1.0.0

    Temperature abuse: Wegovy product was potentially exposed to temperatures outside of the products labeled storage conditions due to a shipping error involving a Cardinal Health distribution center. More specifically, product was removed from refrigerated storage for an extended period of time and inappropriately released.

Field note

Send feedback

We'll only use this to respond to your feedback.